Background. The distribution and elimination of glucose solutions can be analysed by means of a volume kinetic model, but the ability of the model to predict plasma dilution (`model linearity') has not been evaluated.
Glucose solutions are administered i.v. for nutritional and uid balance support following surgery. 1 2 In some countries, glucose is also infused during surgery as a means of supplying`free water', which remains after the glucose has been metabolized, to replace evaporation losses. 3 Glucose given before surgery reduces the insulin resistance resulting from surgical trauma 4 and these solutions given together with insulin may even improve survival during intensive care after cardiac surgery. 5 The¯uid used as a carrier of the glucose constitutes a substantial volume, which should be considered when evaluating the need for plasma volume support. However, the volume effect is dif®cult to predict as water is carried along when glucose is taken up by the cells.
Glucose is usually supplied as a 5% solution, although 2.5% might be more useful in the surgical patient. 6 7 Recently, a volume kinetic model in which the glucose metabolism is considered was used to analyse the distribution and elimination of these¯uids. 8 The proposed model enabled separation of osmotic-driven translocation of¯uid, which is affected by diabetes and postoperative insulin resistance, from dilution-dependent elimination, which also becomes impaired by surgery 9 and blood loss. 10 In the present study we evaluate whether the kinetic model proposed for glucose solutions is linear, that is, whether the kinetic analysis shows the same result regardless of how fast and how much of the¯uid is infused. Linearity is required for the kinetic model to be used to simulate the outcome of experiments not performed. For this purpose, glucose 2.5% was infused at four different rates in six male volunteers. The volumes were differentiated by continuing the infusions for 30 or 60 min.
weight of 60±95 kg (mean 77 kg) agreed to participate. None had a family history of diabetes. On four separate occasions, each volunteer received one i.v. infusion of isoosmotic glucose 2.5% with electrolytes (sodium 70 mmol litre ±1 , chloride 45 mmol litre ±1 and acetate 25 mmol litre ±1 ; Rehydrex, Pharmacia, Uppsala, Sweden) via an infusion pump (Flo-Gard 6201, Baxter Healthcare Ltd, Deer®eld, IL, USA).
The infusion programme was chosen to disclose differences in kinetics by varying the rate of administration (15, 20, 25 and 30 ml kg ±1 h ±1 ) and the infusion time (30 and 60 min) while still aiming at avoiding glycosuria (Table 1) .
Measurements
After fasting overnight, the volunteers rested comfortably on a bed with an equilibration period of at least 30 min before the experiments started at 8.00 a.m. Before any¯uid was administered, one cubital vein on each arm was cannulated. Fluid was infused through one of them. Venous blood was collected from the cannula in the opposite arm every 5 min during the 30-min infusions and every 10 min during the 60-min infusions. After the infusions, venous blood was withdrawn every 10 min up to 90 min and every 15 min thereafter until 120 min after the infusion ended. The heart rate and arterial pressure were measured using an automatic device (Propaq 104, Protocol Systems Inc., Beaverton, OR, USA) immediately after each blood sampling procedure.
The plasma glucose concentration was measured in single samples using the GLU Gluco-quant reagent (Roche Diagnostic Inc., Mannheim, Germany) on a Hitachi 917 (Hitachi Co., Naka, Japan). The blood haemoglobin (Hb) concentration, the red blood cell count (RBC) and the mean corpuscular volume (MCV) were measured in single samples and the baseline in triplicate samples, using a Technicon Advia 120 (Bayer, Tarrytown, NY, USA). Hb was obtained by colorimetry at 546 nm and RBC and MCV were measured by light dispersion at two angles using a helium neon laser. The coef®cient of variation, as calculated from the baseline samples, was 1.0% for Hb, 1.2% for RBC and 0.5% for MCV. The serum concentration of insulin was measured using a Mercodia insulin ELISA kit (Mercodia AB, Uppsala, Sweden) with a coef®cient of variation of 5% for the baseline level and 4.4% for the higher concentrations in the study.
The subjects voided just before the infusions started and, in the recumbent position, whenever necessary during the study. All volunteers also voided at the end of the study. The urine volume and its concentration of glucose, sodium and potassium were measured using a Hitachi 917 System (Hitachi Co., Naka, Japan).
Glucose kinetics and uptake
The WinNonlin Standard 1.5 program (Pharsight Corp., Mountain View, CA, USA) was used to calculate the volume of distribution (V d ), area under the curve (AUC), clearance (CL) and half-life (T 1/2 ) of the infused glucose. The input was the glucose concentration above baseline, and the kinetic analysis was ended when the concentration had returned to baseline. Weights inversely proportional to the predicted concentration were applied. When analysing the results statistically using the F-test, the one-compartment open model was consistently justi®ed.
Since glucose requires active transport to enter the cells, a decreasing amount of glucose in V d corresponds to the uptake of glucose into a peripheral compartment that does not equilibrate with venous plasma. The net uptake of glucose into this remote compartment was calculated for each sampling interval as the product of V d and the incremental change in plasma glucose concentration. During the infusion, the calculation of the incremental net uptake also took account of the amount of glucose added to the system. The equations used for the kinetic analysis and for calculating glucose uptake were given in a previous study. 8 
Volume kinetic models
The distribution and elimination of infused¯uid was studied by volume kinetic analysis 8±10 (Fig. 1 ). An i.v. infusion given at a constant rate (k i ) enters a central body¯uid space having the volume (v 1 ) which strives to be maintained at the baseline volume V 1 by allowing¯uid to leave the space at a controlled rate proportional by a constant k r to the deviation of v 1 from V 1 and at a low basal rate (k b , ®xed rate). Osmotic After metabolism, the¯uid equilibrates again between V 1 and V 3 at a rate determined by k 31 . The elimination of¯uid is given by basal¯uid losses, k b , and a renal mechanism that operates at a rate given by the product of k r and the dilution of V 1 .
Volume effects of glucose 2.5% ¯uid shifts take place between V 1 and a more remote¯uid space, V 3 , and have the strength f(t). As all infused¯uid was isotonic, f(t) is governed in the absence of glycosuria by the net uptake of glucose into the remote compartment and the osmotic pressure of glucose; 3.6 ml water was translocated to v 3 per mmol glucose taken up by V 3 . As water must accompany glucose in order to maintain equal osmolality inside and outside V 3 , the factor 3.6 was obtained from the osmolality of glucose (50 g litre ±1 or 278 mmol litre ±1 being isotonic). In the model,¯uid also returns from v 3 to v 1 , which occurs at a rate proportional by a constant (k 31 ) to the dilution of V 3 . The starting estimate for V 3 in the curve®tting procedure was 40% of the body weight, 11 but the kinetic output is presented as k 31 /V 3 (i.e. the slope for the dilution of V 3 ) as its volume could not be determined with con®dence.
The possibility of a body¯uid space between V 1 and V 3 being expanded was considered by ®tting a three-volume model 8 to the data, but meaningful parameter estimates could not be obtained or the expansion of a third volume was not justi®ed according to the F-test.
Calculations of¯uid distribution
The dilution of the plasma in the cubital vein was used to quantify the water load. As the sampled plasma is a part of V, we obtain:
at the time t of the experiment. The dilution of the RBC count was calculated in the same way as for Hb and the mean value of the two was used after correction for changes in cell volume as indicated by MCV. Furthermore, a correction of the dilution was always made for the withdrawn amount of erythrocytes based on the baseline blood volume, as estimated according to a regression formula based on the height and weight of the subjects. 8 A k b of 0.8 ml min ±1 was used, which represents the sum of the insensible¯uid loss of 0.5 ml min ±1 and the amount of extracellular¯uid withdrawn during blood sampling. 3 The model parameters were calculated on a computer using Matlab version 4.2 (Math Works Inc., Natick, MA, USA), in which a non-linear least-squares regression routine based on a modi®ed Gauss±Newton method was used. Weights inversely proportional to the predicted dilution plus 0.1 were applied.
Predictive performance measures
Computer simulations were made to assess the linearity of the kinetic systems. The residual error between the measured data points in each experiment and the computer-simulated (predicted) values for the group, based on the best parameter estimates according to Tables 2 and 3 , was used to describe how well the kinetic model ®tted the data. The results were expressed as the median residual error, which shows whether the measured data points are systematically higher or lower than the predicted ones (i.e. the bias), and the median absolute residual error, which re¯ects the degree of deviation of measured from predicted data points (i.e. the inaccuracy).
The following equation used V d and CL to obtain the predicted glucose concentration during the infusion:
After the infusion, it is:
where T is the infusion time. The resulting osmotic strength, f(t), and the dilution of V 1 were simulated using solutions to the differential equations described previously.
8 Table 2 Results of pharmacokinetic analysis of the infused glucose molecules when iso-osmotic glucose 2.5% solution was infused in male volunteers. The ®rst line for each parameter gives the mean (SEM) of all estimates in the respective groups. The second line shows the precision of these estimates, speci®ed as the mean (SEM) of the standard errors associated with them. 
Statistics
The results are expressed as the mean (SEM). Data showing a skewed distribution were given as the median and the 25±75th percentile range. The AUC for the plasma glucose and plasma dilution were calculated by the linear trapezoidal method for as long as the data points exceeded baseline. Differences between and during the experiments were evaluated by repeated-measures ANOVA. Correlations between parameters were studied by simple and multiple linear regression; P<0.05 was considered signi®cant.
Results

Glucose kinetics
The plasma glucose concentration increased markedly in response to the infusions (Fig. 2) . Kinetic analysis of the concentration±time curves showed an overall V d for glucose of 9.23 (0.39) litre, a CL of 0.59 (0.04) litre min ±1 and a halflife of 12.8 (1.6) min ( Table 2 ). The AUC vs the amount of administered glucose was the only statistically signi®cant relationship between the infusion parameters and these kinetic parameters (Fig. 3) .
Slight glycosuria (1±5% of the infused amount) was observed during ®ve experiments, while excretion of 8.5% was observed in one patient and 10.5% in another patient. Glycosuria did not in¯uence the kinetics of glucose as indicated by V d and CL.
Fluid kinetics, area approach
The AUC of the dilution±time pro®le increased with the volume of infused glucose solution (Fig. 4A) . The AUC response to infused¯uid tended to change for higher infusion rates, but this relationship was not statistically signi®cant (Fig. 4B ). This lack of linearity could be accounted for by glucosuria, which reduced the AUC (r=±0.51, P<0.01).
Fluid kinetics, compartment analysis
In all 24 experiments, V 1 amounted to 3.14 (0.26) litres, k r to 104 (9) ml min ±1 and the ratio k 31 /V 3 to 5.5 (0.8±12.8) min ±1 . Separate data for the four series of experiments and the corresponding curve ®ts and residual plots are shown in Table 3 and Fig. 5 , respectively.
Predictive performance measures
The ability of the glucose parameters (Table 2 ) and volume kinetic parameters (Table 3) to predict the dilution±time . Data are mean (SEM). Table 3 Volume kinetic parameters and urinary excretion during and after infusion of glucose 2.5% in male volunteers. The ®rst line for each kinetic parameter gives the median (25±75th percentile range) of all estimates in the respective group. The second line shows the precision of these estimates, speci®ed as the mean (SEM) of the standard errors associated with them. V 1 =the size of the central body¯uid space; k r =dilution-dependent elimination rate governed only by excess¯uid in the system; k 31 /V 3 =the slope of the curve for the elimination of¯uid from V 3 curves was evaluated by calculating the residual errors between measured and predicted data. For all 24 experiments, the median residual error was ±0.009 (SEM 0.005) dilution units. Most of this error could be attributed to the inability of the glucose simulation program to predict concentrations below baseline; the dilution of V 1 was therefore slightly overestimated during the late stages of the experiments. This error was reduced to ±0.003 (0.006) on considering only the data obtained during infusion and 30 min after infusion.
The overall median absolute residual error was 0.026 (0.003), which did not change on exclusion of the late stages of the experiments. This error was less than 0.01 dilution units higher when any dilution±time curve was simulated using the average parameter estimates for all 24 experiments, compared with when it was based on its own series of six infusions. These actual differences for the four series of experiments averaged +0.004, ±0.003, ±0.006 and +0.005 (Table 4) .
Urinary excretion and haemodynamics
The proportion of the infused¯uid that was excreted varied very little in the four series of experiments, the overall mean being 62% (Table 3) .
As expected, the renal clearance of the infused¯uid (urine volume divided by the AUC for dilution) correlated with the elimination rate constant (k r ) yielded by the compartment analysis (Fig. 6A) .
The sodium excretion was similar in the groups, the total excretion being 41 (6) mmol (differences were not signi®-cant, Table 3 ). This implies that sodium retention was greater when larger amounts of¯uid were infused, a relationship that was only disturbed by glycosuria (Fig. 6B) . Multiple linear regression analysis con®rmed that both the infused¯uid volume (P<0.001) and glycosuria (inverse correlation, P<0.005) served as independent predictors of sodium retention.
The potassium excretion averaged 19 (2) mmol and differed little between the groups. The highest excretion (66 mmol) occurred in the experiment associated with the most pronounced glycosuria.
The systolic and arterial pressures increased slightly during the experiments, from 123 (2) and 72 (1) mm Hg, respectively, at baseline to 127 (2) (not signi®cant) and 76 (2) mm Hg (P<0.001) at 180 min. The heart rate increased from 62 (2) to 64 (2) beats min ±1 (P<0.001).
Discussion
The¯uid used as a carrier of glucose exhibits complex kinetics. The normal physiological mechanisms operating to eliminate a¯uid overload, involving the action of stretch receptors and hormones, apparently operate alongside osmotically driven distribution, which is strongly dependent on the uptake of infused glucose into the cells. The present study illustrates how these mechanisms interact with each other. For this purpose, glucose 2.5% was infused relatively quickly in volunteers and data on the glucose concentration and the plasma dilution were ®tted to a volume kinetic model adapted for glucose solutions. The kinetic analysis consists of two parts. First, the amount of¯uid translocated to the cells by virtue of glucose uptake is estimated using V d as the calibration factor between the plasma glucose concentration and the amount of glucose that readily equilibrates with the plasma, which mirrors the amount of glucose that has not been taken up by the cells. Secondly, a volume kinetic analysis of the remaining¯uid is made. An estimate of the size of the central body¯uid space expanded by infused¯uid (V 1 ), which is a central concept in volume kinetic theory, 9 10 is made possible by the fact that the dilution of the blood with respect to a large macromolecule such as Hb which does not penetrate vessel walls is a measure of the distribution of the infused¯uid volume, and not of the macromolecule. In contrast, the concentration of small molecules, such as glucose which easily diffuse across vessel walls is a measure Fig 5 (A) Dilution±time curves for individual experiments in which glucose 2.5% was infused at 15, 20, 25 and 30 ml kg ±1 h ±1 in six healthy volunteers (®ne lines) and the model-predicted curve-®t based on the mean glucose uptake for each time interval and the average volume kinetic parameter values shown in Table 3 (thick lines). (B) The residual errors for each individual curve ®t. Table 4 Predictive performance measures. The median residual error and the median absolute residual error in predicting a dilution±time curve from the best estimates of V d and CL (Table 2 ) and V 1 , k r and k 31 /V 3 (Table 3) for any single series of six experiments or for all 24 experiments. The sign of the residual differences is considered in the ®rst error but not in the second one. Calculations were made using the two-stage approach, the reported data being the mean (SEM) of the median residual error of each experiment. Data represent the plasma dilutions (Q 10
±3
) and are without dimensions of the distribution of the molecules and not of the¯uid volume.
The results con®rm previous ®ndings that the net removal of glucose from plasma occurs quite quickly in healthy volunteers. 8 The plasma had been cleared of excess glucose 30 min after the infusions ended. The infused water had also been cleared, although the volume of urine measured 90 min later shows that the osmotic¯uid shift still retained 38% of the infused¯uid in the body. Predictions based on the kinetic data suggested that the excess¯uid in V 3 was between 0.20 and 0.25 litres at the end of the experiments (®gure not shown), which is consistent with the measured urinary excretion provided that we also consider insensible¯u id losses. The cellular volume thus seems to remain expanded for a much longer time than V 1 .
The kinetic analysis indicated that the infused glucose is distributed in a volume three times larger than that of the infused¯uid. No expansion of a body¯uid space between the small V 1 and the remote body¯uid space V 3 could be supported by adding one more exponent to the equation for the dilution±time curve. The lack of a V 2 can probably be explained by the rapid uptake of glucose, which occurred at a rate similar to the expected time course for distribution of uid between V 1 and V 2 . 10 13 Furthermore, the close correlation between k r derived from the urinary excretion and k r estimated by the curve-®tting procedure (Fig. 6A) supports the theory that¯uid was indeed removed from V 1 only by urinary excretion or by uptake into V 3 . In pharmacokinetics, this argument would correspond to the view that a drug is fully eliminated by urinary excretion if the renal CL corresponds closely to the total body CL.
The evaluation of model linearity also consisted of two parts. The ®rst one con®rmed that the AUC for glucose increased in proportion to the dose and that CL was virtually the same regardless of the infusion rate (Fig. 3) . As concerns the¯uid volume, glycosuria reduced the AUC for the plasma dilution and thereby distorted the comparisons (Fig. 4) . However, on removing the cases involving glycosuria, the linearity was almost as good for the¯uid volume as for the glucose.
The second part of the evaluation of linearity was based on predictive performance measures. This is an alternative to comparing the kinetic parameters for the four groups studied. Kinetic parameters usually show some degree of intercorrelation, and it might be dif®cult to judge whether the slightly higher V d and lower CL we observed for higher infusion rates of glucose (Table 2) have any practical meaning, or whether they cancel out when the parameters are used for simulation. The approach used here to assess predictive performance was inspired by a study on infusion pumps, 14 although we report absolute instead of relative errors as a long period of late dilution close to baseline is needed for the estimation of k 31 /V 3 .
The results show that the errors associated with simulation were usually quite small. However, the dilution was usually slightly overestimated during the later stages of the experiments when glucose 2.5% was infused rapidly, mostly because the kinetic model could not take account of dilution below baseline. This limited capacity to deal with`rebound hypoglycaemia' must be kept in mind when simulating an abrupt stop of glucose administration liberal enough to raise the plasma glucose level close to the renal threshold (>12 mmol litre ±1 ). The inaccuracy of simulating by computer, expressed as the median absolute residual error, averaged 0.026 dilution units but, more importantly, it was practically the same when the kinetic parameters used for simulation were based on all 24 infusions, as compared with when they were derived from any of the four subgroups. Hence, using the parameter estimates from the pooled series of infusions did not increase the inaccuracy of the simulations.
Slight glycosuria occurred in several volunteers despite the lack of a family history of diabetes. Glycosuria may occur in healthy patients who receive glucose infusions 2 and might be dif®cult to prevent completely. 15 As could be expected, however, it mostly occurred in the two groups with the highest infusion rates. 6 Glycosuria did not affect the parameters describing glucose kinetics as glucose was cleared from plasma as fast as the¯uid volume. The AUC for plasma dilution was reduced, however, which can, from a kinetic point of view, be attributed to less¯uid being returned from V 3 to V 1 after metabolism of the glucose. This probably explains why the estimates of k 31 /V 3 were lower when glucose was infused at the two highest rates. Computer simulations indicated that k 31 /V 3 governed a slight upward shift of the dilution±time pro®le of V 1 after infusion but otherwise had a quite limited impact on the curve. Variations in glucose kinetics also seemed to have a relatively small in¯uence on V 1 , which was clearly most affected by k r (®gures not shown).
In conclusion, by using an area method and comparing residual errors after simulation, we found linearity for glucose 2.5% when infused at different volumes and rates. Glycosuria and rebound hypoglycaemia appeared to be confounders, however.
